Nektar Therapeutics (NKTR)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Oct 04, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
Nektar Therapeutics Shareholders Equity (Annual): 130.99M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 130.99M |
| December 31, 2022 | 366.64M |
| December 31, 2021 | 679.51M |
| December 31, 2020 | 1.077B |
| December 31, 2019 | 1.405B |
| December 31, 2018 | 1.718B |
| December 31, 2017 | 87.83M |
| December 31, 2016 | 88.12M |
| December 31, 2015 | 6.429M |
| December 31, 2014 | 36.33M |
| December 31, 2013 | -89.90M |
| December 31, 2012 | 47.02M |
| December 31, 2011 | 197.81M |
| December 31, 2010 | 90.66M |
| December 31, 2009 | 102.37M |
| Date | Value |
|---|---|
| December 31, 2008 | 190.15M |
| December 31, 2007 | 214.44M |
| December 31, 2006 | 227.06M |
| December 31, 2005 | 326.81M |
| December 31, 2004 | 467.34M |
| December 31, 2003 | 164.19M |
| December 31, 2002 | 206.77M |
| December 31, 2001 | 270.31M |
| December 31, 2000 | 277.88M |
| December 31, 1999 | 86.63M |
| December 31, 1998 | 115.88M |
| December 31, 1997 | 97.09M |
| December 31, 1996 | 35.10M |
| December 31, 1995 | 20.20M |
| December 31, 1994 | 15.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
130.99M
Minimum
2023
1.405B
Maximum
2019
731.96M
Average
679.51M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Esperion Therapeutics Inc | -454.99M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |